SDGR ($SDGR) Insider Trading & Smart Money Activity
$SDGR has 12 insider trades on file. In the last 12 months on the open market, no insider bought and 1 insider sold ($927.97K), net -$927.97K.
- Insider buyers (12 mo)
- 0
- Insider sellers (12 mo)
- 1
- Net insider $ (12 mo)
- -$927.97K
- Congress trades (12 mo)
- 0
- 13F moves on file
- 0
- Analyst ratings on file
- 0
SDGR insider buying and selling by quarter
| Quarter | Insider buys | Insider sales | Congress buys / sales | 13F added / cut |
|---|---|---|---|---|
| Q1 2026 | 0 | 0 | 0 / 0 | 0 / 0 |
| Q2 2026 | 0 | 0 | 0 / 0 | 0 / 0 |
| Q3 2026 | 0 | 1 · $927.97K | 0 / 0 | 0 / 0 |
| Q4 2026 | 0 | 0 | 0 / 0 | 0 / 0 |
Insider buys and sales count open-market trades only (Form 4 codes P and S). Grants, option exercises and tax withholding are left out.
All SDGR insider, congress, 13F and analyst activity
| Date | Source | Who | Action | Shares | Value / amount | ΔOwn | 1W | 1M | 6M | Filing | Story |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Insider | Akinsanya KarenPresident, Head of Therapeutics R&D and Chief Strategy Officer, Partnerships | Sell (Open-market sale) 10b5-1 | 31.60K sh | $927.97K | — | ||||||
| Insider | Richard Friesner | Sell (Gift) | 679.37K sh | — | |||||||
| Insider | Richard Friesner | Buy (Gift) | 679.37K sh | — | |||||||
| Insider | Van Kralingen Bridget | Buy (Grant or award) | 13.31K sh | — | |||||||
| Insider | Nancy Thornberry | Buy (Grant or award) | 8.14K sh | — | |||||||
| Insider | Gary Sender | Buy (Grant or award) | 8.14K sh | — | |||||||
| Insider | Arun Oberoi | Buy (Grant or award) | 8.14K sh | — | |||||||
| Insider | Michael Lynton | Buy (Grant or award) | 8.14K sh | — | |||||||
| Insider | Rosana Kapeller-Libermann | Buy (Grant or award) | 13.31K sh | — | |||||||
| Insider | Gary Ginsberg | Buy (Grant or award) | 13.31K sh | — | |||||||
| Insider | Richard Friesner | Buy (Grant or award) | 8.14K sh | — | |||||||
| Insider | Jeffrey Chodakewitz | Buy (Grant or award) | 8.14K sh | — |
1W / 1M / 6M = how SDGR moved from the trade or filing date.
Insider trading in SDGR: who is buying and selling
| Insider | Role | Trades | Open-market net | Shares held | Last trade |
|---|---|---|---|---|---|
| Akinsanya Karen | President, Head of Therapeutics R&D and Chief Strategy Officer, Partnerships | 1 | -$927.97K | Sep 17, 2026 | |
| Richard Friesner | 3 | — | Jun 26, 2026 | ||
| Van Kralingen Bridget | 1 | — | Jun 22, 2026 | ||
| Nancy Thornberry | 1 | — | Jun 22, 2026 | ||
| Gary Sender | 1 | — | Jun 22, 2026 | ||
| Arun Oberoi | 1 | — | Jun 22, 2026 | ||
| Michael Lynton | 1 | — | Jun 22, 2026 | ||
| Rosana Kapeller-Libermann | 1 | — | Jun 22, 2026 | ||
| Gary Ginsberg | 1 | — | Jun 22, 2026 | ||
| Jeffrey Chodakewitz | 1 | — | Jun 22, 2026 |
Frequently asked questions
Are SDGR insiders buying or selling?
Over the last 12 months 0 insiders made 0 open-market purchases worth $0 and 1 insider made 1 open-market sale worth $927.97K, a net -$927.97K.
What is the latest insider trade in SDGR?
Akinsanya Karen, President, Head of Therapeutics R&D and Chief Strategy Officer, Partnerships filed a sell (open-market sale) of 31.60K sh worth $927.97K on Sep 17, 2026.
Other health information services stocks
Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.
Get a text when insiders, Congress or big funds trade a stock.
Free. Reply STOP anytime.